Mechanistic Pathways in Disease
Research gap analysis derived from 2 medicine papers in our local library.
The gap
The specific molecular mechanisms linking dietary factors to chronic kidney disease progression require further investigation, particularly through direct mechanistic studies.
Consensus across the literature
While there is evidence of a link between sugar consumption and CKD, the exact pathways remain unclear.
Research trend
Established — well-defined area with open sub-problems.
Supporting evidence — 3 representative gaps
- Sugar-sweetened Beverages and Chronic Kidney Disease (2015) · doi
While substantial evidence exists linking sugar consumption to obesity, diabetes, and hypertension, the direct mechanistic pathway between sugar consumption and CKD development is not yet established.
Keywords: sugar consumption substantial evidence exists linking obesity diabetes hypertension direct mechanistic pathway development established - Sugar-sweetened Beverages and Chronic Kidney Disease (2015) · doi
The direct role of high sugar consumption in the pathogenesis and progression of CKD remains unclear.
Keywords: direct role high sugar consumption pathogenesis progression remains unclear - MiR-362-3p inhibits the proliferation, migration and EMT of gastric cancer cells by regulating the DEP-1/ERK signaling pathway (2026) · doi
Direct mechanistic evidence linking DEP-1 to ERK activation is still lacking.
Keywords: direct mechanistic evidence linking activation still lacking
Explore this gap further
Search “Mechanistic Pathways in Disease” across open scholarly engines for the latest related literature.
Working on this gap? Publish with us.
Science AI Journal reviews manuscripts in under 15 minutes with 8 specialised AI reviewers calibrated on 23,000+ real peer reviews. Open access, CC BY 4.0.
Free tools for your next paper
Related gaps in Medicine
- Liability and legal frameworks for organizations using AI in clinical decision-making processes require development and clarification.Liability and legal frameworks for organizations using AI in clinical decision-making processes require development and clarification.
- Recent literature from 2025 to 2026 has firmly established AI as a core driver in the methodological evolution of precision oncology for HCC. By implementing VFMs to mitigate imaging domain shifts andRecent literature from 2025 to 2026 has firmly established AI as a core driver in the methodological evolution of precision oncology for HCC.…
- PURPOSE: The aim of this review was to critically appraise the literature on the use of antibiotics to treat peri-implantitis, with the ultimate goal of supporting evidence-based clinical recommendatiPURPOSE: The aim of this review was to critically appraise the literature on the use of antibiotics to treat peri-implantitis, with the ulti…
- External validation is required before the model can be applied in clinical settings.External validation is required before the model can be applied in clinical settings.